Literature DB >> 19056300

Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory.

Pooi-See Chan1, Mamta Kanwar, Renu A Kowluru.   

Abstract

Diabetic retinopathy resists arrest of its progression after reestablishment of good glycemic control that follows a profound period of poor glycemic control. The objective of this study was to elucidate the role of inflammation in the resistance of retinopathy to arrest after termination of hyperglycemia. Streptozotocin-diabetic rats were (a) maintained either in poor glycemic control [PC group; glycated hemoglobin (GHb)>11%] or in good glycemic control (GC group; GHb<7%) for 12 months or (b) allowed to be in poor glycemic control for 6 months followed by good glycemic control for 6 additional months. At 12 months, retina was analyzed for pro-inflammatory mediators. Twelve months of PC increased retinal interleukin 1beta (IL-1beta) mRNA by 2-fold and its protein expression by 25% compared with the values obtained from normal rat retina. Tumor necrosis factor alpha (TNF-alpha) was elevated approximately 3-fold (both mRNA and protein), and the receptors for IL-1beta and TNF-alpha were increased by 40% each. The concentrations of intercellular cell adhesion molecule 1 and vascular cell adhesion molecule 1 were elevated by 40% and 150%, respectively, and inducible nitric oxide synthase transcripts were elevated by 6-fold. Six months of good glycemic control that followed 6 months of poor glycemic control failed to reverse the elevations in IL-1beta, TNF receptor type I, and intercellular cell adhesion molecule 1 but had some beneficial effects on TNF-alpha, inducible nitric oxide synthase, and vascular cell adhesion molecule 1, however these mediators remained significantly elevated. However, the GC group showed no significant change in the retinal pro-inflammatory mediators compared with the normal rats. Failure to reverse retinal inflammatory mediators supports their important role in the resistance of retinopathy to arrest after cessation of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056300      PMCID: PMC2804951          DOI: 10.1016/j.jdiacomp.2008.10.002

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  41 in total

1.  Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Nicholas Mitsiades; Bernd Kirchhof; Kan Koizumi; Sven Döhmen; Anthony P Adamis
Journal:  FASEB J       Date:  2002-01-30       Impact factor: 5.191

2.  Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine.

Authors:  Yunpeng Du; Mark A Smith; Casey M Miller; T S Kern
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

3.  Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus.

Authors:  A M Abu El-Asrar; S Desmet; A Meersschaert; L Dralands; L Missotten; K Geboes
Journal:  Am J Ophthalmol       Date:  2001-10       Impact factor: 5.258

4.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

5.  Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats.

Authors:  Renu A Kowluru
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

6.  Endothelial activation is an intermediate step for peripheral lipopolysaccharide induced activation of paraventricular nucleus.

Authors:  Ning Quan; Lingli He; Wenmin Lai
Journal:  Brain Res Bull       Date:  2003-02-15       Impact factor: 4.077

7.  Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.

Authors:  Renu A Kowluru; Prashant Koppolu
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-10       Impact factor: 4.799

8.  Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy.

Authors:  K Matsumoto; Y Sera; Y Ueki; G Inukai; E Niiro; S Miyake
Journal:  Diabet Med       Date:  2002-10       Impact factor: 4.359

9.  Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.

Authors:  Renu A Kowluru; Prashant Koppolu; Subrata Chakrabarti; Shali Chen
Journal:  Free Radic Res       Date:  2003-11

10.  Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.

Authors:  Surya P Ayalasomayajula; Uday B Kompella
Journal:  Eur J Pharmacol       Date:  2003-01-05       Impact factor: 4.432

View more
  35 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

2.  Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes.

Authors:  Renu A Kowluru; Qing Zhong; Mamta Kanwar
Journal:  Exp Eye Res       Date:  2010-02-17       Impact factor: 3.467

Review 3.  Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research.

Authors:  Timothy S Kern; David A Antonetti; Lois E H Smith
Journal:  Ophthalmic Res       Date:  2019-07-30       Impact factor: 2.892

Review 4.  Epigenetic mechanisms in diabetic vascular complications.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  Cardiovasc Res       Date:  2011-01-25       Impact factor: 10.787

5.  Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.

Authors:  Lalit P Singh
Journal:  J Clin Exp Ophthalmol       Date:  2013-08-05

Review 6.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  High levels of glucose induce "metabolic memory" in cardiomyocyte via epigenetic histone H3 lysine 9 methylation.

Authors:  Xi-Yong Yu; Yong-Jian Geng; Jia-Liang Liang; Saidan Zhang; He-Ping Lei; Shi-Long Zhong; Qiu-Xiong Lin; Zhi-Xin Shan; Shu-Guang Lin; Yangxin Li
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

8.  Toll-like receptor 4 regulates insulin signal transduction in retinal Müller cells.

Authors:  Li Liu; Jena J Steinle
Journal:  Growth Factors       Date:  2018-02-28       Impact factor: 2.511

9.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

Review 10.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.